GMAB
USDGenmab A/S ADS
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$28.540
High
$29.390
Low
$28.510
Volume
2.92M
Company Fundamentals
Market Cap
17.8B
Industry
Biotechnology
Country
Denmark
Trading Stats
Avg Volume
2.00M
Exchange
NMS
Currency
USD
52-Week Range
Related News
Genmab to Showcase Latest Blood Cancer Treatment Advancements at 2025 American Society of Hematology (ASH) Annual Meeting
More than 20 abstracts, including seven oral presentations, highlight advancements from the epcoritamab development program supporting the expanded clinical profile and potential of epcoritamab for a broader range of
HC Wainwright & Co. Reiterates Buy on Genmab, Maintains $40 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Genmab with a Buy and maintains $40 price target.
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2025
Company Announcement Net sales of DARZALEX® in the third quarter of 2025 totaled USD 3,672 millionGenmab receives royalties on worldwide net sales from Johnson & Johnson (J&J, legal entity Janssen Biotech,
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.